Onchocerciasis Market: Is Moxidectin Set to Disrupt Three Decades...

adicionou um novo artigo Health

2026-06-29 09:58:42 -

Onchocerciasis Market: Is Moxidectin Set to Disrupt Three Decades of Ivermectin Dominance in River Blindness Control?

Moxidectin's emergence in onchocerciasis treatment — the next-generation macrocyclic lactone achieving 86% greater parasite clearance than ivermectin at one year post-treatment and requiring fewer mass drug administration rounds — represents the most significant therapeutic innovation in river blindness management since Merck's Mectizan donation program began in 1987, with the...

0 Comentários 0 Compartilhamentos 7 Visualizações